Literature DB >> 23047369

Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India.

Babasaheb V Tandale1, Shailesh D Pawar, Yogesh K Gurav, Saurabh S Parkhi, Akhilesh C Mishra.   

Abstract

The healthcare workers having seroprotection at 3 weeks (n = 127) following Pandemic H1N1 2009 influenza vaccination were followed up for antibody persistence. Seroprotection at 12 mo (60.2%) was significantly lower as compared with 3 weeks (74.7%), 3 mo (77.8%) and 6 mo (75.4%). The vaccine provided seroprotection up to one year.

Entities:  

Keywords:  Pandemic H1N1 2009; antibody persistence; healthcare workers; immune response; influenza vaccination; post-licensure

Mesh：

Substances：

Year:  2012        PMID： 23047369      PMCID： PMC3667926          DOI： 10.4161/hv.22421

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  9 in total

1.  Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers.

Authors:  Yi-Chun Lai; Kuen-Cheh Yang; Szu-Min Hsieh; Chien-An Yao; Long-Teng Lee; Kuo-Chin Huang
Journal:  Clin Vaccine Immunol       Date:  2012-01-18

2.  Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India.

Authors:  Babasaheb V Tandale; Shailesh D Pawar; Akhilesh C Mishra
Journal:  Vaccine       Date:  2011-10-14       Impact factor: 3.641

3.  Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.

Authors:  Joon Young Song; Hee Jin Cheong; In Sook Hwang; Won Suk Choi; Yu Mi Jo; Dae Won Park; Geum Joo Cho; Taik Gun Hwang; Woo Joo Kim
Journal:  Vaccine       Date:  2010-04-13       Impact factor: 3.641

4.  Persistence of influenza vaccine-induced antibodies in lung transplant patients between seasons.

Authors:  J J M Moran; W E Rose; A J Darga; K A Rohde; M S Hayney
Journal:  Transpl Infect Dis       Date:  2011-05-27       Impact factor: 2.228

5.  Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.

Authors:  Kwok-Hung Chan; Kelvin K W To; Ivan F N Hung; Anna J X Zhang; Jasper F W Chan; Vincent C C Cheng; Herman Tse; Xiao-Yan Che; Honglin Chen; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

6.  Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Erik Iverson; Gabriel Defang; Patrick J Blair; Lynn E Eberly; Jason Maguire; Anuradha Ganesan; Dennis Faix; Christopher Duplessis; Tahaniyat Lalani; Timothy Whitman; Carolyn Brandt; Grace Macalino; Eugene V Millar; Timothy Burgess
Journal:  Vaccine       Date:  2011-03-01       Impact factor: 3.641

7.  Pandemic influenza (H1N1) 2009 is associated with severe disease in India.

Authors:  Akhilesh C Mishra; Mandeep S Chadha; Manohar L Choudhary; Varsha A Potdar
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

8.  Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.

Authors:  Babasaheb V Tandale; Shailesh D Pawar; Yogesh K Gurav; Mandeep S Chadha; Santosh S Koratkar; Vijay N Shelke; Akhilesh C Mishra
Journal:  BMC Infect Dis       Date:  2010-08-25       Impact factor: 3.090

9.  Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China.

Authors:  Ming Wang; Jun Yuan; Tiegang Li; Yang Liu; Jibin Wu; Biao Di; Xi Chen; Xinhong Xu; Enjie Lu; Kuibiao Li; Yanhui Liu; Yejian Wu; Xiongfei Chen; Peng He; Yulin Wang; Jianhua Liu
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240
  9 in total
  3 in total

1.  Community awareness, use and preference for pandemic influenza vaccines in Pune, India.

Authors:  Neisha Sundaram; Vidula Purohit; Christian Schaetti; Abhay Kudale; Saju Joseph; Mitchell G Weiss
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.

Authors:  Nuriban Valero-Pacheco; Marisol Pérez-Toledo; Miguel Ángel Villasís-Keever; Adriana Núñez-Valencia; Ilka Boscó-Gárate; Bernardo Lozano-Dubernard; Horacio Lara-Puente; Clara Espitia; Celia Alpuche-Aranda; Laura C Bonifaz; Lourdes Arriaga-Pizano; Rodolfo Pastelin-Palacios; Armando Isibasi; Constantino López-Macías
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

3.  Cultural epidemiology of pandemic influenza in urban and rural Pune, India: a cross-sectional, mixed-methods study.

Authors:  Neisha Sundaram; Christian Schaetti; Vidula Purohit; Abhay Kudale; Mitchell G Weiss
Journal:  BMJ Open       Date:  2014-12-08       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.